Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
Open Access
- 1 December 2003
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 40 (12), 865-871
- https://doi.org/10.1136/jmg.40.12.865
Abstract
Background: Mutations of the transforming growth factor β (TGFβ) receptor components ENDOGLIN and ALK-1 cause the autosomal dominant vascular disorder hereditary haemorrhagic telangiectasia (HHT). Heterozygous mutations of the type II receptor BMPR2 underlie familial primary pulmonary hypertension. Objective: To investigate kindreds presenting with both pulmonary hypertension and HHT. Methods: Probands and families were identified by specialist pulmonary hypertension centres in five countries. DNA sequence analysis of ALK-1, ENDOGLIN, and BMPR2 was undertaken. Cellular localisation was investigated by heterologous overexpression of mutant constructs in both BAEC and HeLa cells. The impact of a novel sequence variant was assessed through comparative analysis and computer modelling. Results: Molecular analysis of 11 probands identified eight missense mutations of ALK-1, one of which was observed in two families. Mutations were located within exons 5 to 10 of the ALK-1 gene. The majority of ALK-1 mutant constructs appeared to be retained within the cell cytoplasm, in the endoplasmic reticulum. A novel GS domain mutation, when overexpressed, reached the cell surface but is predicted to disrupt conformational changes owing to loss of a critical hydrogen bond. Two novel missense mutations were identified in ENDOGLIN. Conclusions: The association of pulmonary arterial hypertension and HHT identifies an important disease complication and appears most common among subjects with defects in ALK-1 receptor signalling. Future studies should focus on detailed molecular analysis of the common cellular pathways disrupted by mutations of ALK-1 and BMPR2 that cause inherited pulmonary vascular disease.Keywords
This publication has 29 references indexed in Scilit:
- Visceral manifestations in hereditary haemorrhagic telangiectasia type 2Journal of Medical Genetics, 2003
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Hereditary hemorrhagic telangiectasia: an update on transforming growth factor ? signaling in vasculogenesis and angiogenesisCardiovascular Research, 2003
- The TGFβ Receptor Activation ProcessMolecular Cell, 2001
- Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta familyJournal of Medical Genetics, 2000
- Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12Cell, 1999
- Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β SuperfamilyJournal of Biological Chemistry, 1999
- Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2Nature Genetics, 1996
- Hereditary haemorrhagic telangiectasia: a clinical analysis.Journal of Medical Genetics, 1992
- Pulmonary hypertension in patients with pulmonary arteriovenous fistulae.Heart, 1969